Gene · 10397
Papers3,293
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
201 to 220 of 3,293
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Identification of a Novel CD8+ T cell exhaustion-related gene signature for predicting survival in hepatocellular carcinoma. | BMC Cancer | 2023 | 38049741 | PubTator, text mining | PubMed |
| BMP signaling in cancer stemness and differentiation. | Cell Regen | 2023 | 38049682 | PubTator, text mining | PubMed |
| Diagnosis and treatment of female alopecia: Focusing on the iron deficiency-related alopecia. | Tzu Chi Med J | 2023 | 38035053 | PubTator, text mining | PubMed |
| NEDD4L in human tumors: regulatory mechanisms and dual effects on anti-tumor and pro-tumor. | Front Pharmacol | 2023 | 38027016 | PubTator, text mining | PubMed |
| Current state and challenges of emerging biomarkers for immunotherapy in hepatocellular carcinoma (Review). | Exp Ther Med | 2023 | 38023367 | PubTator, text mining | PubMed |
| Cytohistological and Immunohistochemical Correlation of Cutaneous Mixed Tumors: A Series of Four Cases and Review of Recent Molecular Updates. | Cureus | 2023 | 38021919 | PubTator, text mining | PubMed |
| Neural Marker Expression in Adipose-Derived Stem Cells Grown in PEG-Based 3D Matrix Is Enhanced in the Presence of B27 and CultureOne Supplements. | Int J Mol Sci | 2023 | 38003460 | PubTator, text mining | PubMed |
| The Role of Sirtuin-1 (SIRT1) in the Physiology and Pathophysiology of the Human Placenta. | Int J Mol Sci | 2023 | 38003402 | PubTator, text mining | PubMed |
| Identification of a Novel Oxidative Stress- and Anoikis-Related Prognostic Signature and Its Immune Landscape Analysis in Non-Small Cell Lung Cancer. | Int J Mol Sci | 2023 | 38003378 | PubTator, text mining | PubMed |
| Intercellular Molecular Crosstalk Networks within Invasive and Immunosuppressive Tumor Microenvironment Subtypes Associated with Clinical Outcomes in Four Cancer Types. | Biomedicines | 2023 | 38002057 | PubTator, text mining | PubMed |
| Dpep Inhibits Cancer Cell Growth and Survival via Shared and Context-Dependent Transcriptome Perturbations. | Cancers (Basel) | 2023 | 38001578 | PubTator, text mining | PubMed |
| Fabrication of an Azithromycin Sensor. | Biosensors (Basel) | 2023 | 37998161 | PubTator, text mining | PubMed |
| Integrated single-cell and bulk RNA sequencing analysis identifies a neoadjuvant chemotherapy-related gene signature for predicting survival and therapy in breast cancer. | BMC Med Genomics | 2023 | 37996875 | PubTator, text mining | PubMed |
| LADON, a Natural Antisense Transcript of NODAL, Promotes Tumour Progression and Metastasis in Melanoma. | Noncoding RNA | 2023 | 37987367 | PubTator, text mining | PubMed |
| ELF5 drives angiogenesis suppression though stabilizing WDTC1 in renal cell carcinoma. | Mol Cancer | 2023 | 37980532 | PubTator, text mining | PubMed |
| Construction of an anoikis-associated lncRNA-miRNA-mRNA network reveals the prognostic role of β-elemene in non-small cell lung cancer. | Sci Rep | 2023 | 37980372 | PubTator, text mining | PubMed |
| Retraction Note: LncRNA NDRG1 aggravates osteosarcoma progression and regulates the PI3K/AKT pathway by sponging miR-96-5p. | BMC Cancer | 2023 | 37978354 | PubTator, text mining | PubMed |
| Molecular signature to predict quality of life and survival with glioblastoma using Multiview omics model. | PLoS One | 2023 | 37972206 | PubTator, text mining | PubMed |
| Establishment and verification of a prognostic risk score model based on immune genes for hepatocellular carcinoma in an Asian population. | Transl Cancer Res | 2023 | 37969383 | PubTator, text mining | PubMed |
| The signaling pathway of hypoxia inducible factor in regulating gut homeostasis. | Front Microbiol | 2023 | 37965556 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/10397/papers?page=11